ANDOVER, Mass., Sept. 8, 2011 /PRNewswire/ -- Smith & Nephew (NYSE: SNN) (LSE: SN) today announced the launch of its innovative, single-use DYONICS PLATINUM Series Shaver Blades which deliver superior arthroscopic resection, debris evacuation and sharpness.
The removal of tissue, cartilage and bone is a fundamental component of any arthroscopic repair procedure. The more precise and efficient surgeons are with their technique, the better chance they have of preserving the maximum amount of healthy tissue -- critical to joint stability and to delivering a successful surgical outcome.
The first in a family of eighteen blades to incorporate our new PLATINUM technology are the DYONICS INCISOR™ Plus PLATINUM 4.5 mm Blade and the DYONICS BONECUTTER™ PLATINUM 5.5 mm Blade. Each is designed to deliver best-in-class performance for specific arthroscopy procedures.
- The DYONICS INCISOR™ Plus PLATINUM 4.5 mm Blade is designed to address knee procedures including anterior cruciate ligament (ACL) reconstruction and complex meniscectomies - of which 2.5 million are performed annually. The INCISOR Plus PLATINUM Blade incorporates a precision sharpened, tooth-to-tooth design, allowing it to grab frayed scar tissue or cut thick targeted tendon tissue more efficiently than other competitive blades.
- The DYONICS BONECUTTER™ PLATINUM 5.5 mm Blade is a multifunctional device designed to be used for subacromial decompression procedures in the shoulder and ACL reconstruction in the knee due to its ultra-aggressive resection of thick tissue and hard bone.
"The INCISOR Plus PLATINUM Blade provides the user with the ability to perform aggressive but controlled, precision soft tissue resection. These blades are a joy to use and take soft tissue resection to a new level." said Charles Brown Jr., MD, Abu Dhabi Knee & Sports Medicine Centre, UAE.
Sean Gallimore, Vice President of Arthroscopic Technology Marketing for Smith & Nephew commented, "As an innovator in arthroscopic resection, our goal is to continuously evolve performance and provide world-class solutions. Choosing the right blade is a very important clinical decision which is why we focus on incorporating leading-edge design, technology and materials. Our new DYONICS PLATINUM Series Shaver Blades are designed to raise the bar for resection performance and deliver superior results for surgeons, and ultimately their patients." News
The DYONICS brand helped pioneer mechanical resection for arthroscopy more than 30 years ago. Since that time, Smith & Nephew has introduced a wide array of technological innovations to the DYONICS product line in support of new arthroscopic techniques resulting in the most extensive portfolio of shaver blades and burrs in the industry.
™ Trademark of Smith & Nephew. Certain Marks Reg. U.S. Pat. & T.M. Off.
Media Joe Metzger Smith & Nephew (978) 749-1330 firstname.lastname@example.org
Investor/Analyst Phil Cowdy Smith & Nephew 44 (0)20 7401 7646
About Smith & Nephew
Smith & Nephew is a global medical technology business with global leadership positions in Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine, Trauma and Clinical Therapies. The Company has distribution channels, purchasing agents and buying entities in over 90 countries worldwide. Annual sales in 2010 were nearly $4.0 billion.
Smith & Nephew is dedicated to helping improve people's lives. The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust.
This press release contains certain "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. In particular, statements regarding planned growth in our business and in our operating margins discussed under "Outlook" are forward-looking statements as are discussions of our product pipeline. These statements, as well as the phrases "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions, are generally intended to identify forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors (including, but not limited to, the outcome of litigation and regulatory approvals) that could cause the actual results, performance or achievements of Smith & Nephew, or industry results, to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20F, for a discussion of certain of these factors.
All forward-looking statements in this press release are based on information available to Smith & Nephew as of the date hereof. All written or oral forward-looking statements attributable to Smith & Nephew or any person acting on behalf of Smith & Nephew are expressly qualified in their entirety by the foregoing. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement contained herein to reflect any change in Smith & Nephew's expectation with regard thereto or any change in events, conditions or circumstances on which any such statement is based.
SOURCE Smith & Nephew